159
Participants
Start Date
November 1, 2018
Primary Completion Date
July 21, 2021
Study Completion Date
July 21, 2021
aTIV Primer
MF59-adjuvanted trivalent influenza virus primer: 2 doses (0.25mL) one month apart
QIV Primer
Unadjuvanted quadrivalent influenza vaccine primer: 2 doses (0.5mL) one month apart
aTIV Booster
MF59-adjuvanted influenza virus vaccine booster: 1 dose (0.25mL), year 2
QIV Booster
Unadjuvanted quadrivalent influenza vaccine booster: 1 dose (0.5mL), year 2
Vaccine Evaluation Center, BC Children's Hospital, Vancouver
IWK Health Centre, Halifax
Research Institute of the McGill University health Centre, Montreal
Équipe de recherche en vaccination CHU de Québec-Université Laval, Québec
Provincial Health Services Authority
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Université de Montréal
OTHER
Canadian Center for Vaccinology
OTHER
CHU de Quebec-Universite Laval
OTHER
Dalhousie University
OTHER
Canadian Immunization Research Network
NETWORK